Literature DB >> 11353841

Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide.

S Roy1, C I Bayly, Y Gareau, V M Houtzager, S Kargman, S L Keen, K Rowland, I M Seiden, N A Thornberry, D W Nicholson.   

Abstract

Caspase-3 is synthesized as a dormant proenzyme and is maintained in an inactive conformation by an Asp-Asp-Asp "safety-catch" regulatory tripeptide contained within a flexible loop near the large-subunit/small-subunit junction. Removal of this "safety catch" results in substantially enhanced autocatalytic maturation as well as increased vulnerability to proteolytic activation by upstream proteases in the apoptotic pathway such as caspase-9 and granzyme B. The safety catch functions through multiple ionic interactions that are disrupted by acidification, which occurs in the cytosol of cells during the early stages of apoptosis. We propose that the caspase-3 safety catch is a key regulatory checkpoint in the apoptotic cascade that regulates terminal events in the caspase cascade by modulating the triggering of caspase-3 activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353841      PMCID: PMC33434          DOI: 10.1073/pnas.111085198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Caspase structure, proteolytic substrates, and function during apoptotic cell death.

Authors:  D W Nicholson
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

2.  Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis.

Authors:  S Matsuyama; J Llopis; Q L Deveraux; R Y Tsien; J C Reed
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

Review 3.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

Authors:  W C Earnshaw; L M Martins; S H Kaufmann
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

4.  Autoproteolytic activation of pro-caspases by oligomerization.

Authors:  X Yang; H Y Chang; D Baltimore
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

5.  Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification.

Authors:  R A Gottlieb; J Nordberg; E Skowronski; B M Babior
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

6.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis.

Authors:  J Rotonda; D W Nicholson; K M Fazil; M Gallant; Y Gareau; M Labelle; E P Peterson; D M Rasper; R Ruel; J P Vaillancourt; N A Thornberry; J W Becker
Journal:  Nat Struct Biol       Date:  1996-07

7.  Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases.

Authors:  A Krantz; L J Copp; P J Coles; R A Smith; S B Heard
Journal:  Biochemistry       Date:  1991-05-14       Impact factor: 3.162

8.  RGD peptides induce apoptosis by direct caspase-3 activation.

Authors:  C D Buckley; D Pilling; N V Henriquez; G Parsonage; K Threlfall; D Scheel-Toellner; D L Simmons; A N Akbar; J M Lord; M Salmon
Journal:  Nature       Date:  1999-02-11       Impact factor: 49.962

9.  Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.

Authors:  N A Thornberry; E P Peterson; J J Zhao; A D Howard; P R Griffin; K T Chapman
Journal:  Biochemistry       Date:  1994-04-05       Impact factor: 3.162

10.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Authors:  S L Kargman; G P O'Neill; P J Vickers; J F Evans; J A Mancini; S Jothy
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

View more
  51 in total

1.  The structure of procaspase 6 is similar to that of active mature caspase 6.

Authors:  Byoung Heon Kang; Eunsil Ko; Oh-Keun Kwon; Kwan Yong Choi
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Mutations in the procaspase-3 dimer interface affect the activity of the zymogen.

Authors:  Cristina Pop; Brett Feeney; Ashutosh Tripathy; A Clay Clark
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

3.  Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).

Authors:  Danny C Hsu; Howard S Roth; Diana C West; Rachel C Botham; Chris J Novotny; Steven C Schmid; Paul J Hergenrother
Journal:  ACS Comb Sci       Date:  2011-10-28       Impact factor: 3.784

4.  Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation.

Authors:  Julie A Zorn; Holger Wille; Dennis W Wolan; James A Wells
Journal:  J Am Chem Soc       Date:  2011-11-17       Impact factor: 15.419

5.  Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.

Authors:  Chen Chen; Xin Wei; Xiaoquan Rao; Jun Wu; Shenglan Yang; Fuqiong Chen; Ding Ma; Jianfeng Zhou; Ryan T Dackor; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-10-28       Impact factor: 4.030

6.  L2' loop is critical for caspase-7 active site formation.

Authors:  Witold A Witkowski; Jeanne A Hardy
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

7.  Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation.

Authors:  Nathan D Thomsen; James T Koerber; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

8.  pH effects on the stability and dimerization of procaspase-3.

Authors:  Kakoli Bose; A Clay Clark
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

Review 9.  Self-incompatibility in Papaver pollen: programmed cell death in an acidic environment.

Authors:  Ludi Wang; Zongcheng Lin; Marina Triviño; Moritz K Nowack; Vernonica E Franklin-Tong; Maurice Bosch
Journal:  J Exp Bot       Date:  2019-04-12       Impact factor: 6.992

10.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.